Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,203) with videos related to
Page
of 121
Sort By:
The Oncologist
|
March 29, 2022
COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
Hala T Borno, Mi-Ok Kim, Julian C Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
Won Kim, Li Zhang, John H Wilton, et al.
Prostate Cancer and Prostatic Diseases
|
November 6, 2019
Hyperpolarized <sup>13</sup>C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study
Hsin-Yu Chen, Rahul Aggarwal, Robert A Bok, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
Meenal Sinha, Li Zhang, Sumit Subudhi, et al.
Brain Research
|
February 27, 2001
Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats
S A Stanley, C J Small, K G Murphy, et al.
European Urology Focus
|
September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Stéphane Oudard, Boris Hadaschik, Fred Saad, et al.
Endocrinology
|
September 29, 1998
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo
M Rossi, M S Kim, D G Morgan, et al.
JAMA Oncology
|
June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Shibu Thomas, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases
|
November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer
William S Chen, Eric L Feng, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Page
of 121
Search research articles
Search
Showing results (1001-1010 of 1,203) with videos related to
Sort By:
Page
of 121
The Oncologist
|
March 29, 2022
COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
Hala T Borno, Mi-Ok Kim, Julian C Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
Won Kim, Li Zhang, John H Wilton, et al.
Prostate Cancer and Prostatic Diseases
|
November 6, 2019
Hyperpolarized <sup>13</sup>C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study
Hsin-Yu Chen, Rahul Aggarwal, Robert A Bok, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
Meenal Sinha, Li Zhang, Sumit Subudhi, et al.
Brain Research
|
February 27, 2001
Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats
S A Stanley, C J Small, K G Murphy, et al.
European Urology Focus
|
September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Stéphane Oudard, Boris Hadaschik, Fred Saad, et al.
Endocrinology
|
September 29, 1998
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo
M Rossi, M S Kim, D G Morgan, et al.
JAMA Oncology
|
June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Shibu Thomas, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases
|
November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer
William S Chen, Eric L Feng, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Page
of 121